Skip to main content

Day: June 7, 2023

STMicroelectronics and Sanan Optoelectronics to advance Silicon Carbide ecosystem in China

STMicroelectronics and Sanan Optoelectronics to advance Silicon Carbide ecosystem in ChinaSTMicroelectronics and Sanan Optoelectronics to create a Joint Venture (‘JV’) for high-volume 200mm SiC device manufacturing JV will support rising demand for STMicroelectronics SiC devices in China for car electrification and industrial power and energy applications Sanan to build separately a 200mm SiC substrate manufacturing facility to fulfill the JV’s needsGeneva (Switzerland) and Xiamen (China), June 7, 2023 – STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, and Sanan Optoelectronics (SHA.600703), a market leader in compound semiconductors in China, engaged in LEDs, SiC, Optical Communications, RF, Filters and GaN products, today announced that they have signed...

Continue reading

Genomic Vision présente sa nouvelle orientation stratégique

GENOMIQUE | THÉRAPIES CELLULAIRES ET GÉNIQUES | BIOPRODUCTION                  Genomic Vision présente sa nouvelle orientation stratégiqueFaire progresser l’analyse génomique dans la bioproduction, les thérapies cellulaires et géniques et la découverte de médicaments Mettre en priorité l’innovation pour le contrôle qualité tout au long du cycle de la bioproduction Lancement d’un logiciel d’analyse basé sur l’Intelligence Artificielle (IA) et développement d’une plateforme technologique de nouvelle génération pour accélérer et simplifier l’analyse génomique à haut débitBagneux (France) – Genomic Vision (FR0011799907 – GV, la « Société »), une société de biotechnologie cotée sur Euronext développant des produits et des services pour la caractérisation précise des séquences d’ADN, présente sa nouvelle orientation stratégique. Forte...

Continue reading

Nokia Threat Intelligence Report finds malicious IoT botnet activity has sharply increased

Press release  Nokia Threat Intelligence Report finds malicious IoT botnet activity has sharply increasedNumber of IoT devices (bots) engaged in botnet-driven DDoS attacks rose from around 200,000 a year ago to approximately 1 million devices7 June 2023 Espoo, Finland – The latest Nokia Threat Intelligence Report released today has found that IoT botnet DDoS (Distributed Denial of Service) traffic, originating from a large number of insecure IoT devices with the aim of disrupting telecom network services for millions of users, increased fivefold over the past year, following Russia’s invasion of Ukraine and stemming from the growing increase in profit-driven hacking collectives operated by cybercriminals. This sharp increase, also supplemented by the increased use of IoT devices by consumers around the world, was first noticed at...

Continue reading

Spexis announces the publication of promising results for a novel class of macrocyclic, peptidomimetic antibiotics in Science Advances demonstrating potent in vitro and in vivo antimicrobial activity against MDR and XDR Enterobacteriaceae, including carbapenem-resistant and colistin-resistant strains

Novel antibiotics were developed by Spexis in close collaboration with Professor Oliver Zerbe’s group at the University of Zurich with substantial funding by Innosuisse and CARB-X ALLSCHWIL, Switzerland, June 06, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced the publication of preclinical results from the company’s novel class of macrocyclic, peptidomimetic antibiotics developed in collaboration with the University of Zurich, demonstrating potent in vitro and in vivo antimicrobial activity against multidrug resistant (MDR) and extensively drug resistant (XDR) Enterobacteriaceae. The manuscript, titled “Peptidomimetic Antibiotics Disrupt the Lipopolysaccharide Transport Bridge of Drug-Resistant Enterobacteriaceae,” is available online...

Continue reading

Avance Gas signed newbuilding contract for two Medium-Sized LPG/Ammonia Carriers

Hamilton, Bermuda June 7, 2023Avance Gas Holding Ltd (“Avance Gas” or “the Company”) (OSE: AGAS) has today entered into a newbuilding contract with CIMC for the construction of two mid-sized LPG/ammonia carriers with dual fuel engines that can run on LPG as fuel in addition to compliant fuel oil. The ships will have a cargo capacity of 40,000 cubic meters and scheduled delivery is during the fourth quarter 2025 and the first quarter of 2026. As the ships will also be equipped with shaft generators this will further improve operation and maintenance cost while improving the environmental profile. In addition to transporting traditional LPG cargoes, the vessels will also be fully able to carry ammonia cargoes. The seaborn ammonia trade is expected to grow significantly in the coming years due to the numerous blue and green ammonia projects....

Continue reading

NewAmsterdam Pharma Announces Pricing of Upsized Secondary Offering of Ordinary Shares

NAARDEN, The Netherlands and MIAMI, June 06, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a clinical-stage biopharmaceutical company developing oral, non-statin medicines for patients at high risk of cardiovascular disease with residual elevation of low-density lipoprotein cholesterol, for whom existing therapies are not sufficiently effective or well-tolerated, today announced the pricing of the previously announced underwritten public offering of 13,857,415 shares of the Company’s ordinary shares, with a nominal value of €0.12 per share (“Ordinary Shares,” such offering, the “Offering”) by certain of the Company’s existing shareholders, including affiliates of Forbion Capital Partners (collectively, the “Selling Shareholders”), at a public offering price of $11.50 per...

Continue reading

Day One Announces Pricing of Public Offering of Common Stock

BRISBANE, Calif., June 06, 2023 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced the pricing of its underwritten public offering of 11,538,462 shares of its common stock at a public offering price of $13.00 per share. All shares of common stock are being offered by Day One. The gross proceeds to Day One from the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be approximately $150.0 million. In addition, Day One has granted the underwriters a 30-day option to purchase up to an additional 1,730,769 shares of its common stock at the public offering price, less underwriting discounts...

Continue reading

Gatos Silver Reports Select Unaudited First Quarter 2023 and Fourth Quarter 2022 Results and Provides Update on Financial Restatements

VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) — Gatos Silver, Inc. (NYSE/TSX: GATO) (“Gatos Silver” or the “Company”) today reported operating and select unaudited financial results for the three months ended March 31, 2023 (“Q1 2023”), the three months ended December 31, 2022 (“Q4 2022”) and the year ended December 31, 2022. The Company’s reporting currency is US$. Gatos Silver also provided a corporate update including the status of its financial restatements for 2021 and the first three quarters of 2022. As previously disclosed, the report of full financial results for the first quarter of 2023 and audited financial results for 2022 have been delayed as the Company works on the restatements. The restatement work continues to progress, and the Company continues to believe that required adjustments are non-cash and...

Continue reading

Ryman Hospitality Properties, Inc. Announces Upsizing and Pricing of Common Stock Offering

NASHVILLE, Tenn., June 06, 2023 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”) today announced the upsizing and pricing of its previously announced underwritten registered public offering of shares of its common stock, par value $0.01 per share (the “Offering”). The size of the Offering has been increased from 3,500,000 shares of common stock to 3,850,000 shares of common stock, at a price to the public of $93.25 per share. The Company also granted the underwriters a 30-day option to purchase up to 577,500 additional shares of common stock. The Offering is expected to close on or about June 9, 2023, subject to customary closing conditions. The Company expects to contribute the net proceeds of the Offering to RHP Hotel Properties, LP (the “Operating Partnership”). The Operating Partnership intends...

Continue reading

Voxtur Announces Exclusive Strategic Partnership with Top 3 Mortgage Originator and Aggregator

TORONTO and TAMPA, Fla., June 06, 2023 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a North American technology company creating a more transparent and accessible real estate lending ecosystem, announced today an exclusive, strategic partnership with one of the largest FHA and VA lenders in the United States to implement Voxtur’s mortgage asset trading platform, Blue Water’s new Correspondent-as-a-Service (“CaaS”) platform. More specifically, CaaS is a rules-based transaction platform that facilitates pricing, commitment, transfer and transaction of whole loans and mortgage servicing rights (“MSR”) with a single click. The system also comes bundled with Blue Water’s patent-pending, loan-level pricing engine, an order management and allocation system, and an ability to seamlessly...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.